Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Third-party claim

Rules 1.1.0 · as of 14 Sep 2026

Christian Angermayer · Said 18 Feb 2026 · angermayer-0155

Quote

Third-party claim

“Yesterday's $CMPS update reconfirmed the expected timeline: a Q4 2026 NDA submission and an early 2027 commercial launch for COMP360 psilocybin. If this timeline holds, 2027 will mark the year in which psychedelic therapy becomes accessible to patients in the US within a regulated medical framework.”
· Christian Angermayer on X: Almost 10 years ago, I made the decision to bring psychedelics back into modern medicine · tweet

Long tweet marking almost ten years since he decided to bring psychedelics into medicine; he adopts Compass's guidance (Q4 2026 NDA, early 2027 launch) and draws the conclusion that 2027 is the year regulated psychedelic therapy reaches US patients.

A quoted or paraphrased claim by someone else that the author does not adopt as their own.

← Earlier · Later → · All statements